GREEN CARDAMOM SUPPLEMENTATION IMPROVES SERUM GLUCOSE INDICES, LIPIDS, INFLAMMATORY FACTORS, PARAOXONASE-1, SIRTUIN-1, AND IRISIN IN OVERWEIGHT OR OBESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL

Publish Year: 1397
نوع سند: مقاله کنفرانسی
زبان: English
View: 431

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

INC15_008

تاریخ نمایه سازی: 30 دی 1397

Abstract:

Background and Aim: Nonalcoholic fatty liver disease (NAFLD) as hepatic component of metabolic syndrome and health benefits of green cardamom (GC) in the human need to be further studied. The aim was assessing the effects of GC on blood glucose indices, lipids, inflammatory factors, and liver enzymes, irisin, paraoxonase-1 (PON1), and sirtuin-1 (Sirt1) in obese NAFLD patients.Methods: The trial-conducting place was the National Iranian Oil Company (NIOC) Central Hospital. Participants according to the eligibility criteria were randomly divided into two groups (GC [n=43], placebo [n=44], 2×500mg capsules, 3-times/day/meal for 3-months, follow-up monthly). General characteristics and dietary and physical activity status were assessed. At the beginning and end, anthropometrics (WT, HT, BMI, WC), blood pressure (SBP, DBP), fatty liver grade, and serum glucose indices (FBS, FBI, HOMA-IR, QUICKI), lipids (TG, LDL-c, HDL-c, TC), inflammatory markers (hs-CRP, TNF-α, IL-6), liver enzymes (ALT, AST), irisin, PON1, and Sirt1 were determined.Results: During the study, dietary vitamins E and B6 intakes in the GC group were significantly higher. GC compared with placebo significantly increased HDL-c, PON1, Sirt1, irisin, and QUICKI and decreased WC, FBI, TG, LDL-c, HOMA-IR, hs-CRP, TNF-α, IL-6, and ALT. In the adjusted model, significant changes were similar, although the decrease in LDL-c had a trend. In the end, the improvement of the fatty liver grade was significant in the GC group compared with placebo (P<0.05).Conclusion: The GC supplementation in obese NAFLD patients improved WC, FBI, HOMA-IR, TG, hs-CRP, TNF-α, IL-6, ALT, QUICKI, HDL-c, irisin, PON1, and Sirt1. Further trials of GC’s potential are suggested.

Keywords:

Non-alcoholic fatty liver disease , Green cardamom , Obesity , Overweight , Iran

Authors

Milad Daneshi-Maskooni

Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences

Seyed Ali Keshavarz

Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences

Mostafa Qorbani

Non-Communicable Diseases Research Center, Alborz University of Medical Sciences

Siavash Mansouri

Gastroenterohepatology Department, National Iranian Oil Company (NIOC) Central Hospital